Evaluation of topical cyclosporine for the treatment of dry eye disease

Archives of Ophthalmology

Volumn 126, Issue 8, 2008, Pages 1046-1050

  Perry, Henry D ^a,b   Solomon, Renée ^a   Donnenfeld, Eric D ^a,c   Perry, Alicia R ^a   Wittpenn, John R ^a   Greenman, Herb E ^a   Savage, Howard E ^b  

^a OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN A; DYE; FLUORESCEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIRMER TEST; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; CYCLOSPORINE; DRUG EVALUATION; DRY EYE SYNDROMES; FEMALE; FLUORESCEIN; FLUOROPHOTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LISSAMINE GREEN DYES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TEARS;

EID: 49449090225     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.8.1046     Document Type: Article

References (19)

1. Nussenblatt RB, Palestine AG. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986;31(3):159-169.
2. Belin MW, Bouchard CS, Frantz S, Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmology. 1989;96(8):1144-1150.
3. Perry HD, Donnenfeld ED, Kanellopoulos AJ, Grossman GA. Topical cyclosporine A in the management of post-keratoplasty glaucoma. Cornea. 1997;16(3):284-288.
4. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631-639.
5. Stonecipher K, Perry HD, Gross RH, Kerney DL. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca. Curr Med Res Opin. 2005;21(7):1057-1063.
6. Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000;19(4):492-496.
7. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118(11):1489-1496.
8. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate to severe dry eye disease: a doseranging, randomized trial, The Cyclosporine A Group. Ophthalmology. 2000;107(5):967-974.
9. Wilson SE, Perry HD. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporin A treatment. Ophthalmology. 2007;114(1):76-79.
10. Perry HD, Carnevale-Doshi S, Donnenfeld ED, et al. Efficacy of topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25(2):171-175.
11. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. Ophthalmology. 1999;106(4):811-816.
12. Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea. 2007;26(7):805-809.
13. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid lowering medications: a cross-national study. JAMA. 1998;279(18):1458-1462.
14. Tsai JC, McClure CA, Ramos SE, Schlundt DGD, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393-398.
15. Winfield AJ, Jessiman D, Williams A, Eskowitz I. Study of non-compliance in patients prescribed eyedrops. Br J Ophthalmol. 1990;74(8):477-480.
16. Coll J, Anglada J, Tomas S, et al. High prevalence of subclinical Sjogren's syndrome features in patients with autoimmune thyroid disease. J Rheumatol. 1997;24(9):1719-1724.
17. Herr KA, Mobily PR. Chronic pain and depression. J Psychosoc Nurs Ment Health Serv. 1992;30(9):7-12.
18. Gudbjörnsson B, Karlsson-Parra A, Karlsson E, Hallgren R, Kampe O. Clinical and laboratory features of Sjogren's syndrome in young women with previous postpartum thyroiditis. J Rheumatol. 1994;21(2):215-219.
19. Pérez B, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D. Autoimmune thyroid disease in primary Sjogren's syndrome. Am J Med. 1995;99(5):480-484.